FDA Approvals Monthly Roundup: August 2020 The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs. Each month, the administration approves numerous new therapeutics. We have summarized the FDA
FDA Approvals Monthly Roundup: July 2020 The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs. Each month, the administration approves numerous new therapeutics. We have summarized the FDA
Feature Announcements Join us on Kaysen's Quest: Learn more about Gene Therapy, Zolgensma As a company that specializes in drug information, DrugBank always tries to remain informed about novel treatments, drug approvals, and drugs that are impacting global health. At the top of our minds lately
Announcements FDA Approvals Monthly Roundup: June 2020 The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs. Each month, the administration approves numerous new therapeutics. We have summarized the FDA
press releases Edmonton Startup, DrugBank, Graduates from Creative Destruction Lab - West May 27, 2020 - Edmonton based startup, DrugBank, recently graduated from the 2019/20 Creative Destruction Lab (CDL) Program. CDL is a seed-stage accelerator program for massively scalable, science-based companies. Its nine-month program
COVID19 DrugBank joins as a supporter of Global Virtual Partnering Event to accelerate partnerships in the life sciences industry to fight COVID-19 PRESS CONTACT Shay Barker Operations Manager, DrugBank [email protected] FOR IMMEDIATE RELEASE April 20, 2020 - DrugBank is pleased to announce they’ve joined a 3-day global virtual partnering event, organized by
White Paper UPDATED: COVID-19: Finding the Right Fit With the global outbreak of COVID-19 spanning news stations and research labs across the world, the DrugBank team put their heads together to provide an overview of current data-driven approaches to identify potential COVID-19 therapies.
Edmonton Startup, DrugBank, Wins Inaugural Startup TNT $125,000 Investment PRESS CONTACT Shay Barker Operations Manager, DrugBank [email protected] FOR IMMEDIATE RELEASE February 21, 2020 - DrugBank, a local Edmonton technology startup, is the inaugural winner of the Startup TNT Investment Pitch
FDA Approval Roundup - December 2019 Last month the FDA approved ten new drugs aimed at treating a broad spectrum of diseases and ailments. The FDA often approves a number of drugs over a short period of time before
The DrugBank team is headed to the Valley! With the temperatures dropping substantially here in Alberta, the DrugBank team is excited to be headed to the sunshine in Santa Clara, California from January 21 - 24 for the Precision Medicine World
Announcements A Year in Review: DrugBank's 2019 Highlights Happy New Year from our team here at DrugBank! 2019 was a wild year for us, and we wanted to share some of our top highlights with you: 1. We added 8 new
Edmonton Startup DrugBank Pledges to Offset Company Travel Carbon Emissions Co-Founders, Michael Wilson and Craig Knox, along with their team, have pledged to mitigate their travel emissions by purchasing carbon offsets for all business-related travel. With the help of Less Emissions, a Bullfrogpower
press releases Edmonton Startup DrugBank accepted into Creative Destruction Lab - West 2019/20 Cohort Edmonton based startup, DrugBank, has been accepted into the 2019/20 Creative Destruction Lab (CDL) program year. CDL is a seed-stage program for massively scalable, science-based companies. Its nine-month program pairs founders with
Announcements DrugBank is Crossing the Pond! JOIN US AT THE 2019 AI IN DRUG DEVELOPMENT CONGRESS. We are hopping on a red-eye this week headed to London, UK, to take part in the 2019 AI in Drug Development Congress.
Use Cases Using DrugBank Data in AI Drug Discovery: A Case Study High-quality data is the first step for training Machine-Learning (ML) and Artificial Intelligence (AI) algorithms, but obtaining this information is difficult as most knowledge about drugs exists within scientific publications in an unstructured text format. This is where DrugBank comes in.
Feature Announcements DrugBank Fall 2019 Feature Release The DrugBank team is proud to announce our Fall 2019 Feature Release. See the exciting updates below to learn about simple & clinical descriptions, supplemental ingredients, and more enhancements!
Announcements DrugBank wins Prairie High-Growth Startup of the Year Award by Startup Canada Startup Canada Press Release: DrugBank received the Startup Canada Prairie High-Growth Startup of the Year Award in Edmonton, presented by Mastercard Canada. As a proud sponsor of the sixth annual Startup Canada Awards,
In the News Cannabinoids in Epilepsy: A New Era of Treatments In a groundbreaking announcement, a Food and Drug Administration (FDA) advisory panel gave their unanimous recommendation in April 2018 for the approval of Epidiolex, a cannabis-derived product shown to be effective for the treatment of two forms of treatment-resistant childhood epilepsies.
In the News From Discovery to Resistance to Progress Progress on resistance: The discovery of malacidins, a class of chemicals made by bacteria found in soil, is an exciting advancement and will hopefully make way for near future discovery of much needed broad-spectrum antibiotics.
Announcements DrugBank partners with Ontotext to accelerate Pharma Research DrugBank is pleased to announce its partnership with OntoText, which will empower commercial and academic Pharma and Healthcare researchers even further in their efforts to discover and repurpose drugs for treating various illnesses.
In the News Ketamine: the key to treatment resistant depression? The treatment of depression can be a complex blend of art and science as the pathophysiology remains poorly understood. Here we explore Ketamine, a drug that has proven to have an important place in medicine and a possibly ground-breaking place in treatment of depression.
In the News Tideglusib: From Alzheimer's to Caries Lesion Natural Repair Nowadays, it is fairly common in science to discover that a drug with an initial indication can be repurposed to target a completely different condition; this is the case with Tideglusib.
Feature Announcements New Feature: Biopharmaceutical Classification Recently, we have been working on adding allergenics, vaccines, and other biopharmaceuticals to DrugBank. In order to allow easy filtering of these new datasets, we have created a simple biopharmaceutical classification system which we outline here.
In the News CFTR Modulators Helping Cystic Fibrosis Patients Catch Their Breath Orkambi and Kalydeco are members of a new generation of medications that are making history for people living with Cystic Fibrosis. These treatments focus on improving underlying lung function rather than simply delaying its decline...
In the News New Antivirals Provide Hope for Eradication of Hepatitis C – If You Can Afford It We’ve been lucky enough to find ourselves in the golden age of antivirals. Effective medications for the management of infectious diseases like Hepatitis C and HIV have revolutionized care. Unfortunately, promises of eradication mean nothing if the drug can’t find its way into the hands of patients.
